Loading…
A PEGylated Fibrin-Based Wound Dressing with Antimicrobial and Angiogenic Activity
Wounds sustained under battlefield conditions are considered to be contaminated and their initial treatment should focus on decreasing this contamination and thus reducing the possibility of infection. The early and aggressive administration of antimicrobial treatment starting with intervention on t...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Report |
Language: | English |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Seetharaman, Shanmuganathan Natesan, Shanmugasundaram Stowers, Ryan S Mullens, Conor Baer, David G Suggs, Laura J Christy, Robert J |
description | Wounds sustained under battlefield conditions are considered to be contaminated and their initial treatment should focus on decreasing this contamination and thus reducing the possibility of infection. The early and aggressive administration of antimicrobial treatment starting with intervention on the battlefield has resulted in improved patient outcomes and is considered the standard of care. Chitosan microspheres (CSM) loaded with silver sulfadiazine (SSD) were developed via a novel water-in-oil emulsion technique to address this problem. The SSD-loaded spheres were porous with needle-like structures (attributed to SSD) that were evenly distributed over the spheres. The average particle size of the SSD CSM was 125 180 micro m with 76.50 2.8% drug entrapment. As a potential new wound dressing with angiogenic activity SSD CSM particles were impregnated in polyethylene glycol (PEGylated) fibrin gels. In vitro drug release studies showed that a burst release of 27.02% in 6 h was achieved, with controlled release for 72 h, with an equilibrium concentration of 27.7% (70 micro g). SSD CSM PEGylated fibrin gels were able to exhibit microbicidal activity at 125 and 100 micro gml -1 against Staphylococcus aureus and Pseudomonas aeruginosa, respectively. The in vitro vasculogenic activity of this composite dressing was shown by seeding adipose-derived stem cells (ASC) in SSD CSM PEGylated fibrin gels. The ASC spontaneously formed microvascular tube-like structures without the addition of any exogenous factors. This provides a method for the extended release of an antimicrobial drug in a matrix that may provide an excellent cellular environment for revascularization of infected wounds.
Published in Acta Biomaterialia, v7 p2787-2796, 2011. |
format | report |
fullrecord | <record><control><sourceid>dtic_1RU</sourceid><recordid>TN_cdi_dtic_stinet_ADA618958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ADA618958</sourcerecordid><originalsourceid>FETCH-dtic_stinet_ADA6189583</originalsourceid><addsrcrecordid>eNrjZAhyVAhwda_MSSxJTVFwy0wqyszTdUosBnLC80vzUhRcilKLizPz0hXKM0syFBzzSjJzM5OL8pMyE3MUEoHyjnnpmfnpqXmZyQqOySWZZZkllTwMrGmJOcWpvFCam0HGzTXE2UM3pSQzOb64JDMvtSTe0cXRzNDC0tTCmIA0AFvONF8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>A PEGylated Fibrin-Based Wound Dressing with Antimicrobial and Angiogenic Activity</title><source>DTIC Technical Reports</source><creator>Seetharaman, Shanmuganathan ; Natesan, Shanmugasundaram ; Stowers, Ryan S ; Mullens, Conor ; Baer, David G ; Suggs, Laura J ; Christy, Robert J</creator><creatorcontrib>Seetharaman, Shanmuganathan ; Natesan, Shanmugasundaram ; Stowers, Ryan S ; Mullens, Conor ; Baer, David G ; Suggs, Laura J ; Christy, Robert J ; ARMY INST OF SURGICAL RESEARCH FORT SAM HOUSTON TX</creatorcontrib><description>Wounds sustained under battlefield conditions are considered to be contaminated and their initial treatment should focus on decreasing this contamination and thus reducing the possibility of infection. The early and aggressive administration of antimicrobial treatment starting with intervention on the battlefield has resulted in improved patient outcomes and is considered the standard of care. Chitosan microspheres (CSM) loaded with silver sulfadiazine (SSD) were developed via a novel water-in-oil emulsion technique to address this problem. The SSD-loaded spheres were porous with needle-like structures (attributed to SSD) that were evenly distributed over the spheres. The average particle size of the SSD CSM was 125 180 micro m with 76.50 2.8% drug entrapment. As a potential new wound dressing with angiogenic activity SSD CSM particles were impregnated in polyethylene glycol (PEGylated) fibrin gels. In vitro drug release studies showed that a burst release of 27.02% in 6 h was achieved, with controlled release for 72 h, with an equilibrium concentration of 27.7% (70 micro g). SSD CSM PEGylated fibrin gels were able to exhibit microbicidal activity at 125 and 100 micro gml -1 against Staphylococcus aureus and Pseudomonas aeruginosa, respectively. The in vitro vasculogenic activity of this composite dressing was shown by seeding adipose-derived stem cells (ASC) in SSD CSM PEGylated fibrin gels. The ASC spontaneously formed microvascular tube-like structures without the addition of any exogenous factors. This provides a method for the extended release of an antimicrobial drug in a matrix that may provide an excellent cellular environment for revascularization of infected wounds.
Published in Acta Biomaterialia, v7 p2787-2796, 2011.</description><language>eng</language><subject>ANGIOGENESIS ; ANTIMICROBIAL AGENTS ; ASC(ADIPOSE-DERIVED STEM CELLS) ; CSM(CHITOSAN MICROSPHERES) ; DRESSINGS ; DRUGS ; FIBRIN ; Medical Facilities, Equipment and Supplies ; Medicine and Medical Research ; PARTICLE SIZE ; PEG(POLYETHYLENE GLYCOL) ; PEGYLATED FIBRIN-BASED WOUND DRESSINGS ; Pharmacology ; POLYETHYLENE ; SILVER ; SSD CSM PARTICLES ; SSD(SILVER SULFADIAZINE) ; SSD-CSM-PEGYLATED FIBRIN GELS ; STEM CELLS ; SULFADIAZINE ; WOUNDS AND INJURIES</subject><creationdate>2011</creationdate><rights>Approved for public release; distribution is unlimited.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,780,885,27567,27568</link.rule.ids><linktorsrc>$$Uhttps://apps.dtic.mil/sti/citations/ADA618958$$EView_record_in_DTIC$$FView_record_in_$$GDTIC$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Seetharaman, Shanmuganathan</creatorcontrib><creatorcontrib>Natesan, Shanmugasundaram</creatorcontrib><creatorcontrib>Stowers, Ryan S</creatorcontrib><creatorcontrib>Mullens, Conor</creatorcontrib><creatorcontrib>Baer, David G</creatorcontrib><creatorcontrib>Suggs, Laura J</creatorcontrib><creatorcontrib>Christy, Robert J</creatorcontrib><creatorcontrib>ARMY INST OF SURGICAL RESEARCH FORT SAM HOUSTON TX</creatorcontrib><title>A PEGylated Fibrin-Based Wound Dressing with Antimicrobial and Angiogenic Activity</title><description>Wounds sustained under battlefield conditions are considered to be contaminated and their initial treatment should focus on decreasing this contamination and thus reducing the possibility of infection. The early and aggressive administration of antimicrobial treatment starting with intervention on the battlefield has resulted in improved patient outcomes and is considered the standard of care. Chitosan microspheres (CSM) loaded with silver sulfadiazine (SSD) were developed via a novel water-in-oil emulsion technique to address this problem. The SSD-loaded spheres were porous with needle-like structures (attributed to SSD) that were evenly distributed over the spheres. The average particle size of the SSD CSM was 125 180 micro m with 76.50 2.8% drug entrapment. As a potential new wound dressing with angiogenic activity SSD CSM particles were impregnated in polyethylene glycol (PEGylated) fibrin gels. In vitro drug release studies showed that a burst release of 27.02% in 6 h was achieved, with controlled release for 72 h, with an equilibrium concentration of 27.7% (70 micro g). SSD CSM PEGylated fibrin gels were able to exhibit microbicidal activity at 125 and 100 micro gml -1 against Staphylococcus aureus and Pseudomonas aeruginosa, respectively. The in vitro vasculogenic activity of this composite dressing was shown by seeding adipose-derived stem cells (ASC) in SSD CSM PEGylated fibrin gels. The ASC spontaneously formed microvascular tube-like structures without the addition of any exogenous factors. This provides a method for the extended release of an antimicrobial drug in a matrix that may provide an excellent cellular environment for revascularization of infected wounds.
Published in Acta Biomaterialia, v7 p2787-2796, 2011.</description><subject>ANGIOGENESIS</subject><subject>ANTIMICROBIAL AGENTS</subject><subject>ASC(ADIPOSE-DERIVED STEM CELLS)</subject><subject>CSM(CHITOSAN MICROSPHERES)</subject><subject>DRESSINGS</subject><subject>DRUGS</subject><subject>FIBRIN</subject><subject>Medical Facilities, Equipment and Supplies</subject><subject>Medicine and Medical Research</subject><subject>PARTICLE SIZE</subject><subject>PEG(POLYETHYLENE GLYCOL)</subject><subject>PEGYLATED FIBRIN-BASED WOUND DRESSINGS</subject><subject>Pharmacology</subject><subject>POLYETHYLENE</subject><subject>SILVER</subject><subject>SSD CSM PARTICLES</subject><subject>SSD(SILVER SULFADIAZINE)</subject><subject>SSD-CSM-PEGYLATED FIBRIN GELS</subject><subject>STEM CELLS</subject><subject>SULFADIAZINE</subject><subject>WOUNDS AND INJURIES</subject><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2011</creationdate><recordtype>report</recordtype><sourceid>1RU</sourceid><recordid>eNrjZAhyVAhwda_MSSxJTVFwy0wqyszTdUosBnLC80vzUhRcilKLizPz0hXKM0syFBzzSjJzM5OL8pMyE3MUEoHyjnnpmfnpqXmZyQqOySWZZZkllTwMrGmJOcWpvFCam0HGzTXE2UM3pSQzOb64JDMvtSTe0cXRzNDC0tTCmIA0AFvONF8</recordid><startdate>20110413</startdate><enddate>20110413</enddate><creator>Seetharaman, Shanmuganathan</creator><creator>Natesan, Shanmugasundaram</creator><creator>Stowers, Ryan S</creator><creator>Mullens, Conor</creator><creator>Baer, David G</creator><creator>Suggs, Laura J</creator><creator>Christy, Robert J</creator><scope>1RU</scope><scope>BHM</scope></search><sort><creationdate>20110413</creationdate><title>A PEGylated Fibrin-Based Wound Dressing with Antimicrobial and Angiogenic Activity</title><author>Seetharaman, Shanmuganathan ; Natesan, Shanmugasundaram ; Stowers, Ryan S ; Mullens, Conor ; Baer, David G ; Suggs, Laura J ; Christy, Robert J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-dtic_stinet_ADA6189583</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2011</creationdate><topic>ANGIOGENESIS</topic><topic>ANTIMICROBIAL AGENTS</topic><topic>ASC(ADIPOSE-DERIVED STEM CELLS)</topic><topic>CSM(CHITOSAN MICROSPHERES)</topic><topic>DRESSINGS</topic><topic>DRUGS</topic><topic>FIBRIN</topic><topic>Medical Facilities, Equipment and Supplies</topic><topic>Medicine and Medical Research</topic><topic>PARTICLE SIZE</topic><topic>PEG(POLYETHYLENE GLYCOL)</topic><topic>PEGYLATED FIBRIN-BASED WOUND DRESSINGS</topic><topic>Pharmacology</topic><topic>POLYETHYLENE</topic><topic>SILVER</topic><topic>SSD CSM PARTICLES</topic><topic>SSD(SILVER SULFADIAZINE)</topic><topic>SSD-CSM-PEGYLATED FIBRIN GELS</topic><topic>STEM CELLS</topic><topic>SULFADIAZINE</topic><topic>WOUNDS AND INJURIES</topic><toplevel>online_resources</toplevel><creatorcontrib>Seetharaman, Shanmuganathan</creatorcontrib><creatorcontrib>Natesan, Shanmugasundaram</creatorcontrib><creatorcontrib>Stowers, Ryan S</creatorcontrib><creatorcontrib>Mullens, Conor</creatorcontrib><creatorcontrib>Baer, David G</creatorcontrib><creatorcontrib>Suggs, Laura J</creatorcontrib><creatorcontrib>Christy, Robert J</creatorcontrib><creatorcontrib>ARMY INST OF SURGICAL RESEARCH FORT SAM HOUSTON TX</creatorcontrib><collection>DTIC Technical Reports</collection><collection>DTIC STINET</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Seetharaman, Shanmuganathan</au><au>Natesan, Shanmugasundaram</au><au>Stowers, Ryan S</au><au>Mullens, Conor</au><au>Baer, David G</au><au>Suggs, Laura J</au><au>Christy, Robert J</au><aucorp>ARMY INST OF SURGICAL RESEARCH FORT SAM HOUSTON TX</aucorp><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><btitle>A PEGylated Fibrin-Based Wound Dressing with Antimicrobial and Angiogenic Activity</btitle><date>2011-04-13</date><risdate>2011</risdate><abstract>Wounds sustained under battlefield conditions are considered to be contaminated and their initial treatment should focus on decreasing this contamination and thus reducing the possibility of infection. The early and aggressive administration of antimicrobial treatment starting with intervention on the battlefield has resulted in improved patient outcomes and is considered the standard of care. Chitosan microspheres (CSM) loaded with silver sulfadiazine (SSD) were developed via a novel water-in-oil emulsion technique to address this problem. The SSD-loaded spheres were porous with needle-like structures (attributed to SSD) that were evenly distributed over the spheres. The average particle size of the SSD CSM was 125 180 micro m with 76.50 2.8% drug entrapment. As a potential new wound dressing with angiogenic activity SSD CSM particles were impregnated in polyethylene glycol (PEGylated) fibrin gels. In vitro drug release studies showed that a burst release of 27.02% in 6 h was achieved, with controlled release for 72 h, with an equilibrium concentration of 27.7% (70 micro g). SSD CSM PEGylated fibrin gels were able to exhibit microbicidal activity at 125 and 100 micro gml -1 against Staphylococcus aureus and Pseudomonas aeruginosa, respectively. The in vitro vasculogenic activity of this composite dressing was shown by seeding adipose-derived stem cells (ASC) in SSD CSM PEGylated fibrin gels. The ASC spontaneously formed microvascular tube-like structures without the addition of any exogenous factors. This provides a method for the extended release of an antimicrobial drug in a matrix that may provide an excellent cellular environment for revascularization of infected wounds.
Published in Acta Biomaterialia, v7 p2787-2796, 2011.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_dtic_stinet_ADA618958 |
source | DTIC Technical Reports |
subjects | ANGIOGENESIS ANTIMICROBIAL AGENTS ASC(ADIPOSE-DERIVED STEM CELLS) CSM(CHITOSAN MICROSPHERES) DRESSINGS DRUGS FIBRIN Medical Facilities, Equipment and Supplies Medicine and Medical Research PARTICLE SIZE PEG(POLYETHYLENE GLYCOL) PEGYLATED FIBRIN-BASED WOUND DRESSINGS Pharmacology POLYETHYLENE SILVER SSD CSM PARTICLES SSD(SILVER SULFADIAZINE) SSD-CSM-PEGYLATED FIBRIN GELS STEM CELLS SULFADIAZINE WOUNDS AND INJURIES |
title | A PEGylated Fibrin-Based Wound Dressing with Antimicrobial and Angiogenic Activity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T01%3A51%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-dtic_1RU&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.btitle=A%20PEGylated%20Fibrin-Based%20Wound%20Dressing%20with%20Antimicrobial%20and%20Angiogenic%20Activity&rft.au=Seetharaman,%20Shanmuganathan&rft.aucorp=ARMY%20INST%20OF%20SURGICAL%20RESEARCH%20FORT%20SAM%20HOUSTON%20TX&rft.date=2011-04-13&rft_id=info:doi/&rft_dat=%3Cdtic_1RU%3EADA618958%3C/dtic_1RU%3E%3Cgrp_id%3Ecdi_FETCH-dtic_stinet_ADA6189583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |